These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10320627)

  • 21. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction.
    Valdez IH; Wolff A; Atkinson JC; Macynski AA; Fox PC
    Cancer; 1993 Mar; 71(5):1848-51. PubMed ID: 8448748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of saliva in oral health: strategies for prevention and management of xerostomia.
    Brosky ME
    J Support Oncol; 2007 May; 5(5):215-25. PubMed ID: 17564151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of radiation therapy-induced salivary gland dysfunction in mice by post therapy IGF-1 administration.
    Grundmann O; Fillinger JL; Victory KR; Burd R; Limesand KH
    BMC Cancer; 2010 Aug; 10():417. PubMed ID: 20698985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry.
    Valdez IH; Atkinson JC; Ship JA; Fox PC
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):41-7. PubMed ID: 8416881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Future therapy strategies for salivary gland impairment].
    Aframian DJ; Palmon A; Nahlieli O
    Refuat Hapeh Vehashinayim (1993); 2004 Jul; 21(3):43-50, 93. PubMed ID: 15503981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
    Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
    J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy.
    Davies AN; Thompson J
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003782. PubMed ID: 26436597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of stem cells in the prevention and treatment of radiation-induced xerostomia in patients with head and neck cancer.
    Nevens D; Nuyts S
    Cancer Med; 2016 Jun; 5(6):1147-53. PubMed ID: 26880659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new approach to prevent radiation-induced xerostomia using intraglandular injection of mitochondria-boosting agents.
    Farhadi M; Fadavi P; Mohebbi S; Taghizadeh-Hesary F
    BMC Cancer; 2024 Jul; 24(1):832. PubMed ID: 38992600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Outcome of primary combined radio-chemotherapy in head and neck tumors with simultaneous salivary gland protection by amifostine].
    Schultze J; Kimmig B
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():13-7. PubMed ID: 10584134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing radiation induced xerostomia.
    Koukourakis MI; Danielidis V
    Cancer Treat Rev; 2005 Nov; 31(7):546-54. PubMed ID: 16257125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of salivary hypofunction during and after radiotherapy.
    Shiboski CH; Hodgson TA; Ship JA; Schiødt M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S66.e1-19. PubMed ID: 17379158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
    Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
    Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer.
    Gornitsky M; Shenouda G; Sultanem K; Katz H; Hier M; Black M; Velly AM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jul; 98(1):45-52. PubMed ID: 15243470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current ideas to reduce or salvage radiation damage to salivary glands.
    Vissink A; van Luijk P; Langendijk JA; Coppes RP
    Oral Dis; 2015 Jan; 21(1):e1-10. PubMed ID: 24581290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Research advances in prevention of radiation induced xerostomia by intensity-modulated radiation therapy].
    Yan C; Wang ZH
    Shanghai Kou Qiang Yi Xue; 2008 Oct; 17(5):540-4. PubMed ID: 18989600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TAT-mediated delivery of Tousled protein to salivary glands protects against radiation-induced hypofunction.
    Sunavala-Dossabhoy G; Palaniyandi S; Richardson C; De Benedetti A; Schrott L; Caldito G
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):257-65. PubMed ID: 22285666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic Phenotypes Underlying Radiation-Induced Salivary Gland Dysfunction.
    Gunning JA; Limesand KH
    J Dent Res; 2024 Jul; 103(8):778-786. PubMed ID: 38808518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
    Horiot JC; Lipinski F; Schraub S; Maulard-Durdux C; Bensadoun RJ; Ardiet JM; Bolla M; Coscas Y; Baillet F; Coche-Dequéant B; Urbajtel M; Montbarbon X; Bourdin S; Wibault M; Alfonsi M; Calais G; Desprez P; Pene F; Lapeyre M; Vinke J; Maral J
    Radiother Oncol; 2000 Jun; 55(3):233-9. PubMed ID: 11041775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired salivary dysfunction. Drugs and radiation.
    Fox PC
    Ann N Y Acad Sci; 1998 Apr; 842():132-7. PubMed ID: 9599303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.